Your search returned 7 results.

Results
	1.	Modeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorder. [electronic resource] by Lalovic, Bojan Hutmacher, Matt Frame, Bill Miller, Raymond Producer: 20110823 In: Journal of clinical pharmacology vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A population pharmacokinetic model of cabozantinib in healthy volunteers and patients with various cancer types. [electronic resource] by Lacy, Steven Yang, Bei Nielsen, Jace Miles, Dale Nguyen, Linh Hutmacher, Matt Producer: 20190605 In: Cancer chemotherapy and pharmacology vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Population exposure-response analysis of cabozantinib efficacy and safety endpoints in patients with renal cell carcinoma. [electronic resource] by Lacy, Steven Nielsen, Jace Yang, Bei Miles, Dale Nguyen, Linh Hutmacher, Matt Producer: 20190605 In: Cancer chemotherapy and pharmacology vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. [electronic resource] by Don, Burl R Spin, Gregory Nestorov, Ivan Hutmacher, Matt Rose, Aubri Kaysen, George A Producer: 20061214 In: The Journal of pharmacy and pharmacology vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Dosing celecoxib in pediatric patients with juvenile rheumatoid arthritis. [electronic resource] by Krishnaswami, Sriram Hutmacher, Matt M Robbins, Jeffery L Bello, Akintunde West, Christine Bloom, Bradley J Producer: 20130308 In: Journal of clinical pharmacology vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Population pharmacokinetics of pegaptanib in patients with neovascular, age-related macular degeneration. [electronic resource] by Basile, Anthony S Hutmacher, Matt Nickens, Dana Nielsen, Jace Kowalski, Ken Whitfield, Lloyd Masayo, Oishi Nakane, Masami Producer: 20130308 In: Journal of clinical pharmacology vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Exposure-response analysis in patients with schizophrenia to assess the effect of asenapine on QTc prolongation. [electronic resource] by Chapel, Sunny Hutmacher, Matt M Haig, George Bockbrader, Howard de Greef, Rik Preskorn, Sheldon H Lalonde, Richard L Producer: 20100107 In: Journal of clinical pharmacology vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)